Bessemer Group Inc. Has $158.49 Million Stock Position in Cardinal Health, Inc. $CAH

Bessemer Group Inc. grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 7,053.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 750,038 shares of the company’s stock after acquiring an additional 739,553 shares during the period. Bessemer Group Inc.’s holdings in Cardinal Health were worth $158,491,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Aventura Private Wealth LLC acquired a new stake in Cardinal Health in the fourth quarter valued at $25,000. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health during the 4th quarter worth about $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health during the 4th quarter worth about $27,000. Indiana Trust & Investment Management Co bought a new stake in shares of Cardinal Health in the 1st quarter valued at about $29,000. Finally, Palladiem LLC bought a new stake in shares of Cardinal Health in the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on CAH shares. William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Bank of America upped their target price on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Evercore decreased their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. JPMorgan Chase & Co. lowered their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Finally, Wells Fargo & Company dropped their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $249.13.

Cardinal Health Trading Up 1.8%

CAH stock opened at $228.88 on Friday. The stock has a 50-day moving average price of $215.36 and a 200-day moving average price of $213.66. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $243.21. The firm has a market cap of $53.61 billion, a PE ratio of 35.00, a price-to-earnings-growth ratio of 1.10 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the previous year, the business earned $2.35 EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 10.77 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s payout ratio is presently 31.50%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.